ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.94415
0.15%
Brent Oil
83.925
0.44%
Bitcoin
61,194.82
0.01%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Amphastar Pharmaceuticals Inc (AMPH)

  7. Amphastar Pharmaceuticals Inc (AMPH) Noticias

AMPH

Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AMPH
FechaHoraFuenteTítuloSímboloCompañía
08/05/202415:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/03/202415:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
01/03/202415:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
29/02/202415:53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/02/202416:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/11/202315:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
12/09/202311:10Dow Jones NewsAmphastar Pharmaceuticals Shares Down 9% After Private Notes OfferingNASDAQ:AMPHAmphastar Pharmaceuticals Inc
16/08/202316:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
21/06/202316:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
15/06/202315:08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/06/202305:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/05/202315:55Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/04/202306:42Dow Jones NewsEli Lilly to Sell Baqsimi Product to AmphastarNASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/04/202305:45PR Newswire (US)Lilly to Divest BAQSIMI to AmphastarNASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202315:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202315:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
01/03/202315:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/02/202310:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/08/202205:55TipRanksNeedham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/06/202213:05TipRanksAmphastar Pharmaceuticals (AMPH) Receives a Hold from NeedhamNASDAQ:AMPHAmphastar Pharmaceuticals Inc
24/05/202211:25TipRanksNeedham Maintains a Hold Rating on Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
14/04/202215:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
13/04/202210:35TipRanksNeedham Maintains Their Hold Rating on Amphastar Pharmaceuticals (AMPH)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
08/04/202209:45TipRanksAmphastar Pharmaceuticals (AMPH) Gets a Hold Rating from NeedhamNASDAQ:AMPHAmphastar Pharmaceuticals Inc
09/11/202115:34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AMPHAmphastar Pharmaceuticals Inc
15/06/202115:05GlobeNewswire Inc.Amphastar Pharmaceuticals to Present at the Raymond James Human Health Innovation ConferenceNASDAQ:AMPHAmphastar Pharmaceuticals Inc
27/05/202105:00GlobeNewswire Inc.Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare ConferenceNASDAQ:AMPHAmphastar Pharmaceuticals Inc
07/05/202115:05GlobeNewswire Inc.Amphastar Announces Buyback of 26% of the Equity in its ANP Subsidiary and Spin-off its Hanxin SubsidiaryNASDAQ:AMPHAmphastar Pharmaceuticals Inc
06/05/202115:05GlobeNewswire Inc.Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021NASDAQ:AMPHAmphastar Pharmaceuticals Inc
03/05/202105:00GlobeNewswire Inc.Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate InjectionNASDAQ:AMPHAmphastar Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AMPH

Su Consulta Reciente

COIN
SOLUSD
Solana
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
USOTC
BASFY
BASF (QX)
FX
EURUSD
Euro vs US Dollar
NYSE
MRK
Merck
AMEX
XLF
Financial Select Sector
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
NASDAQ
AAPL
Apple
NYSE
VZ
Verizon Communications
AMEX
XLE
Energy Select Sector SPDR
NYSE
CVX
Chevron
AMEX
XLV
Health Care Select Sector
AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados